Return to search

Leuko secures $1.8 mln seed

Boston and Madrid-based Leuko, a developer of a non-invasive white blood cell monitoring device, has raised $1.8 million in seed financing. The investors included Good Growth Capital, Pegasus Tech Ventures and Nina Capital.

Source: Press Release